Skip to main content

Table 1 Patient characteristics at baseline

From: Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib – results from a non-interventional multi-center study

 

FAS (N = 270)

SAF (N = 338)

Age [years]

n (number of patients)

270

338

Mean (SD)

66.9 (9.4)

66.9 (9.1)

Median (Min, Max)

69 (38, 83)

69 (38, 83)

Body mass index [kg/m2]

n (number of patients)

270

338

Mean (SD)

24.2 (4.2)

24.4 (4.3)

Median (Min, Max)

24 (15, 47)

24 (15, 47)

Sex [% (n)] a

Male

59.3 (160)

60.1 (203)

Female

40.7 (110)

39.9 (135)

Smoking status [n (%)] a

Non-smoker

177 (65.6)

230 (68.0)

Current smoker

45 (16.7)

50 (14.8)

Former smoker

39 (14.4)

48 (14.2)

Missing data

9 (3.3)

10 (3.0)

  1. aPercentages are based on the total number of patients in each analysis set